“Pipeline”

39 result(s)
Specialty
The Top Challenges Facing Gene Therapy Today More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines More
Briefing
Cost Management
Managing Treatment Costs for Pulmonary Arterial Hypertension More
Briefing
Cost Management
New Dry Powder Inhalation Therapies for PAH in Pipeline More
Briefing
Specialty
Biosimilars Can Be Part of a Strategy to Lower Specialty Drug Costs More
Briefing
Drug Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon More
Briefing
Drug Pipeline
As more treatments for inflammatory bowel disease are approved, payors can counter cost increases with comprehensive utilization management. More
Briefing
Drug Pipeline
... More
Briefing
Drug Pipeline
The gene therapy pipeline report highlights what payors can expect for a variety of conditions. More
Briefing